The Makers of the Omnipod® System
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, USA, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, many patients across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives.
Starting July 2018, Insulet began direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allowed Insulet to be closer to the diabetes community and to identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.
Get in touch
Learn more about Insulet Corporation, an innovative medical device company based outside of Boston, MA, U.S.A.
Our team is committed to making a difference in the lives of people with diabetes.
Partner with Insulet Delivery Systems Group to deliver the full potential of your drug via the Pod.
Media and Investor Inquiries
We would be happy to talk to you further. Please contact us via mail, phone, or email:
100 Nagog Park
Acton, MA 01720
US Corporate telephone: 001 978 600 7850
US Corporate fax: 001 978 600 0120
Insulet International Ltd.
- Registry: Registered in England and Wales
- Registered Number: 10695788
- Registered and Office Address: 1 King Street, 5th Floor, London, W6 9HR
- VAT number: UK: 272 9652 71